By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Clearside Biomedical 

1220 Old Alpharetta Road
Suite 300
Alpharetta   Georgia  30005  U.S.A.
Phone: 678-270-3631 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Clearside Biomedical To Present At International Symposium On Ocular Pharmacology And Therapeutics (ISOPT) Clinical Meeting 7/9/2015 8:13:24 AM
Clearside Biomedical Announces Favorable End-of-Phase 2 Review With The FDA 6/16/2015 11:30:49 AM
Clearside Biomedical And Santen, Inc. Announce Research Collaboration In Glaucoma 5/4/2015 8:22:42 AM
Clearside Biomedical To Report Efficacy And Safety Results In Non-Infectious Uveitis Using A Single Suprachoroidal Injection Of Triamcinolone Acetonide At 2015 ARVO Meeting 4/30/2015 1:25:53 PM
Spark Therapeutics (ONCE) And Clearside Biomedical Announce Exclusive Option To License Technology For Potentially Differentiated Delivery Of Gene Therapy To The Eye 4/29/2015 6:55:09 AM
Clearside Biomedical Announces Purchase Of Iscience Patent Portfolio For Suprachoroidal Space Drug Delivery 4/22/2015 10:41:46 AM
Clearside Biomedical Reports Efficacy And Safety Results In Non-Infectious Uveitis Using A Single Suprachoroidal Injection Of Triamcinolone Acetonide 3/16/2015 11:08:45 AM
Clearside Biomedical Initiates Phase 2 Clinical Trial To Evaluate Reducing Treatment Visits While Improving Outcomes In Macular Edema Associated With Retinal Vein Occlusion 3/2/2015 11:29:52 AM
Clearside Biomedical Initiates Phase 2 Clinical Trial For The Treatment Of Macular Edema Associated With Non-Infectious Uveitis 1/6/2015 9:31:21 AM
Clearside Biomedical Announces Ongoing Results In Phase 1/2 Clinical Trial In Patients With Non-infectious Uveitis 10/15/2014 10:54:50 AM
123
//-->